FrancophonIA/ELRC3.0 huggingface dataset:
English: In case of poor tolerability of the 5 microgram dose, the dose should be reduced to 2.5 microgram iloprost.
Estonian: 5 mikrogrammise annuse halva talumise korral tuleb annust vähendada 2,5 mikrogrammi iloprostini.
English: • pain in jaw/spasm of the jaw muscles (trismus)
Estonian: • lõuavalu/lõualihaste spasm (trism);
English: There is no need to alter the dose in patients with mild or moderate kidney problems (patients with a creatinine clearance >30 ml/min).
Estonian: Kergete või mõõdukate neeruhäiretega (kreatiniini kliirens > 30 ml/min) patsientidel ei ole annuse muutmine vajalik.
English: Caution is recommended in case of co-administration of Ventavis with other antihypertensive or vasodilatating agents as dose adjustment might be required.
Estonian: Ventavis'e koosmanustamisel muude vererõhku alandavate või veresooni laiendavate preparaatidega tuleb olla ettevaatlik, sest vajalikuks võib osutuda annuse kohandamine.
English: No studies to investigate the metabolism of iloprost were performed following inhalation of Ventavis.
Estonian: Ventavis'e inhalatsioonijärgsed uuringud iloprosti metabolismi uurimiseks puuduvad.
English: Any Ventavis solution remaining in the nebuliser must be thrown away.
Estonian: Pärast inhalatsiooni nebulisaatorisse järele jäänud Ventavis'e lahus tuleb ära visata.
English: 30 ampoules with 1 ml 42 ampoules with 1 ml Multipack: 168 (4 x 42) ampoules with 1 ml
Estonian: 30 AMPULLI 1 ML LAHUSEGA 42 AMPULLI 1 ML LAHUSEGA 168 (4 X 42) AMPULLI 1 ML LAHUSEGA
English: Ventavis 10 microgram/ml nebuliser solution 4 years.
Estonian: Ventavis 10 mikrogrammi/ml nebuliseeritav lahus 4 aastat
English: PACK WITH 30 AMPOULES IN A CARTON WITH 90 (3 x 30) AMPOULES WITH 2 ML PACK WITH 30 AMPOULES IN A CARTON WITH 300 (10 x 30) AMPOULES WITH 2 ML
Estonian: KARP 30 AMPULLIGA, PAKENDIS 90 (3 X 30) AMPULLI 2 ML LAHUSEGA KARP 30 AMPULLIGA, PAKENDIS 300 (10 X 30) AMPULLI 2 ML LAHUSEGA
English: 4.2 Posology and method of administration Drug product
Estonian: 4.2 Annustamine ja manustamisviis Ravim
English: Syncope is a common symptom of the disease itself, but can also occur under therapy.
Estonian: Minestus on haiguse enda sagedaseks sümptomiks, kuid võib samuti esineda ravi ajal.
English: Ventavis 20 microgram/ml nebuliser solution 5 years.
Estonian: Ventavis 20 mikrogrammi/ml nebuliseeritav lahus 5 aastat
English: No disturbance of post-natal development and reproductive performance was seen in animals exposed during lactation.
Estonian: Imetamise ajal ravimiga kokkupuutes olnud loomadel ei täheldatud häireid postnataalses arengus ega reproduktsioonivõimes.
English: For Ventavis 20 microgram/ml (5 microgram dose), the medication chamber with the golden coloured latch is used together with the golden control disc.
Estonian: Ventavis 20 mikrogrammi/ml (5 mikrogrammine annus) jaoks kasutatakse kuldse fiksaatoriga ravimikambrit koos kuldse kontrollkettaga.
English: • fast heartbeat (tachycardia)
Estonian: • kiire südamerütm (tahhükardia);
English: You should not switch to another nebuliser without consulting the doctor who is treating you.
Estonian: Ärge hakake kasutama mõnda teist nebulisaatorit ilma oma raviarstiga eelnevalt nõu pidamata.
English: Part of a multipack containing 168 (4 x 42) ampoules with 1 ml.
Estonian: Osa mitmikpakendist, mis sisaldab 168 (4 x 42) ampulli 1 ml lahusega.
English: PACK WITH 42 AMPOULES IN A CARTON WITH 168 (4 x 42) AMPOULES WITH 1 ML PACK WITH 42 AMPOULES IN A CARTON WITH 168 (4 x 42) AMPOULES WITH 1 ML CO-PACKED WITH BREELIB CONSUMABLES SET
Estonian: KARP 42 AMPULLIGA, PAKENDIS 168 (4 x 42) AMPULLI 1 ML LAHUSEGA KARP 42 AMPULLIGA, PAKENDIS 168 (4 X 42) AMPULLI 1 ML LAHUSEGA, PAKENDATUNA KOOS BREELIB'I TARVIKUTEGA
English: The I-Neb AAD nebuliser has been shown to be suitable for the administration of Ventavis 10 microgram/ml (1 ml ampoule) and 20 microgram/ml nebuliser solution.
Estonian: I-Neb AAD nebulisaator sobib Ventavis 10 mikrogrammi/ml (1 ml ampull) ja 20 mikrogrammi/ml nebuliseeritava lahuse manustamiseks.
English: For the 2.5 microgram dose of Ventavis 10 microgram/ml the medication chamber with the red coloured latch is used together with the red control disc.
Estonian: 2,5 mikrogrammise annuse jaoks Ventavis 10 mikrogrammi/ml manustamisel kasutatakse punase fiksaatoriga ravimikambrit koos punase kontrollkettaga.
English: A mean increase in the 6-minute walk test of 44.7 metres from a baseline mean value of 329 metres vs. a change of -7.4 metres from a baseline mean value of 324 metres in the placebo group (no data imputation for death or missing values) was observed in the subgroup of 49 patients with primary pulmonary hypertension receiving treatment of inhaled iloprost for 12 weeks (46 patients in the placebo group).
Estonian: 49 primaarse pulmonaalse hüpertensiooniga patsientide alagrupis, kes said iloprosti inhalatsiooniravi 12 nädala jooksul (platseebogrupis 46 patsienti) kasvas keskmine 6-minutilise käimistesti tulemus 44,7 meetri võrra baastasemelt 329 meetrit, võrreldes muutusega -7,4 meetrit baastasemelt 324 meetrit platseebogrupis (ilma puuduvate andmete või surmade tingliku arvestamiseta).
English: Dose per inhalation session
Estonian: Annus inhalatsiooniseansi kohta
English: Since the I-Neb AAD system can be used for Ventavis 10 microgram/ml and Ventavis 20 microgram/ml, the table below provides a summary of the user instructions of the I-Neb for the 2 concentrations of Ventavis:
Estonian: Kuna I-Neb AAD süsteemi saab kasutada nii Ventavis 10 mikrogrammi/ml, kui ka Ventavis 20 mikrogrammi/ml lahuse jaoks, on allolevas tabelis toodud kasutusjuhised Ventavis'e mõlema tugevuse inhaleerimiseks.
English: Your doctor will supervise your treatment if switching from Ventavis 10 microgram /ml to Ventavis 20 microgram/ml to monitor how well you tolerate the higher concentration.
Estonian: Üleminekul Ventavis'e 10 mikrogrammi/ml tugevuselt 20 mikrogrammi/ml-le, jälgib arst teie ravi kulgu, jälgimaks kui hästi te seda tugevamat lahust talute.
English: 1 ml ampoule white - yellow ring
Estonian: 1 ml ampull Rõnga värvus: valge-kollane
English: • disturbed sense of taste (dysgeusia)
Estonian: • maitsehäire (düsgeusia).
English: Bayer B.V. Tel: +31-(0)297-28 06 66
Estonian: Tel: +31-(0)297-28 06 66
English: Just before you start to inhale, break the glass ampoule containing 2 ml solution, which has two coloured rings (white-pink), and pour the complete contents into the nebuliser medication chamber.
Estonian: Vahetult enne inhalatsiooni alustamist murdke lahti 2 ml lahust sisaldav klaasampull, millel on kaks värvilist rõngast (valge-roosa) ja valage kogu selle sisu nebulisaatori ravimikambrisse.
English: If this dose is well tolerated, dosing should be increased to 5 microgram iloprost using 2 ml ampoule of Ventavis 10 microgram/ml and maintained at that dose.
Estonian: Kui seda annust talutakse hästi, tuleb annust suurendada 5 mikrogrammi iloprostini (kasutades Ventavis 10 mikrogrammi/ml 2 ml-st ampulli) ja jätkata selle annusega.
English: • For the inhalation you should use a mouthpiece to prevent Ventavis coming into contact with your skin.
Estonian: • Takistamaks Ventavis'e kokkupuudet nahaga, kasutage inhalatsiooniks huulikut.
English: How to store Ventavis
Estonian: Kuidas Ventavis't säilitada
English: The ampoules containing 1 ml are marked with two coloured rings (yellow-red).
Estonian: 1 ml lahust sisaldavatel ampullidel on kaks värvilist rõngast (kollane-punane).
English: Ventavis 10 microgram/ml nebuliser solution Clear, colourless solution.
Estonian: Ventavis 10 mikrogrammi/ml nebuliseeritav lahus Selge, värvitu lahus.
English: The I-Neb AAD nebuliser has been shown to be suitable for the administration of Ventavis 10 microgram/ml (1 ml ampoule with white and yellow rings).
Estonian: I-Neb AAD nebulisaator sobib Ventavis 10 mikrogrammi/ml (1 ml ampull, millel on valge ja kollane rõngas) manustamiseks.
English: If this dose is well tolerated, dosing should be increased to 5 microgram iloprost using 1 ml ampoule of Ventavis 10 microgram/ml and maintained at that dose.
Estonian: Kui seda annust talutakse hästi, tuleb annust suurendada 5 mikrogrammi iloprostini (kasutades Ventavis 10 mikrogrammi/ml 1 ml-st ampulli) ja jätkata selle annusega.
English: Venta-Neb, a portable ultrasonic battery-powered nebuliser, has also been shown to be suitable for the administration of Ventavis 10 microgram/ml.
Estonian: Venta-Neb on kaasaskantav patareitoitel ultraheli-nebulisaator, mis sobib Ventavis'e tugevuse 10 mikrogrammi/ml manustamiseks.
English: Musculoskeletal and connective tissue disorders
Estonian: Lihas-skeleti ja sidekoe kahjustused lõuavalu/lõuakramp
English: How to use Ventavis
Estonian: Kuidas Ventavis't kasutada
English: If any of these happen when you have used more Ventavis than you should:
Estonian: Kui te olete kasutanud Ventavis't rohkem kui ette nähtud ja teil tekib mõni neist loetletud seisunditest:
English: Ampoules with 1 ml nebuliser solution (for the use of Breelib or I-Neb AAD):
Estonian: 1 ml nebuliseeritavat lahust sisaldavad ampullid (kasutamiseks Breelib või I-Neb AAD nebulisaatoriga)
English: Start therapy by inhaling 2.5 microgram iloprost using Ventavis 10 micrograms/ml (1 ml ampoule with white and yellow rings).
Estonian: Alustage ravi 2,5 mikrogrammi iloprosti inhaleerimisega, kasutades selleks Ventavis 10 mikrogrammi/ml (1 ml ampull, mis on märgistatud valge ja kollase rõngaga).
English: Start therapy by inhaling 2.5 microgram iloprost using 1 ml ampoule of Ventavis 10 microgram/ml (with white and yellow rings).
Estonian: Alustage ravi 2,5 mikrogrammi iloprosti inhaleerimisega, kasutades selleks Ventavis 10 mikrogrammi/ml 1 ml ampulli (märgistatud valge ja kollase rõngaga).
English: Ventavis 20 microgram/ml nebuliser solution Clear, colourless to slightly yellowish solution.
Estonian: Ventavis 20 mikrogrammi/ml nebuliseeritav lahus Selge, värvitu kuni kergelt kollakas lahus.
English: • stop the inhalation session
Estonian: • katkestage inhalatsiooniseanss;
English: 2.5 mcg
Estonian: 2,5 mikrogrammi
English: Multipack: 168 (4 x 42) ampoules with 1 ml.
Estonian: Mitmikpakend: 168 (4 x 42) ampulli x 1 ml
English: Ventavis 20 mcg/ml (1 ml ampoule with yellow and red rings)
Estonian: 20 mikrogrammi/ml (1 ml ampull, mis on märgistatud kollase ja punase rõngaga)
English: At initiation of Ventavis treatment the first inhaled dose should be 2.5 microgram iloprost as delivered at the mouthpiece of the nebuliser.
Estonian: Ventavis'e ravi alustamisel peab esimene inhaleeritav annus olema 2,5 mikrogrammi iloprosti, doseerituna nebulisaatori huuliku juures.
English: Venta-Neb, a portable ultrasonic battery-powered nebuliser, has been shown to be suitable for the administration of Ventavis 10 microgram/ml nebuliser solution (2 ml ampoule).
Estonian: Venta-Neb on kaasaskantav patareitoitel ultraheli-nebulisaator, mis sobib Ventavis 10 mikrogrammi/ml nebuliseeritava lahuse (2 ml ampull) manustamiseks.
English: Since the I-Neb AAD nebuliser can be used for Ventavis 10 microgram/ml and Ventavis 20 microgram/ ml, the table below provides a summary of the user instructions of the I-Neb for the 2 concentrations of Ventavis:
Estonian: Kuna I-Neb AAD nebulisaatorit saab kasutada nii Ventavis 10 mikrogrammi/ml, kui ka Ventavis 20 mikrogrammi/ml lahuse jaoks, on allolevas tabelis toodud kasutusjuhised Ventavis'e mõlema tugevuse inhaleerimiseks.
English: If you tolerate this dose well, your dose should be increased to 5 microgram and you should continue on this dose.
Estonian: Kui te talute seda annust hästi, tuleb annust tõsta kuni 5 mikrogrammi iloprostini ning te peate jätkama ravi selle annusega.
English: • swelling of the limbs (peripheral oedema)
Estonian: • jäsemete paistetus (perifeerne turse).
English: If you are starting Ventavis treatment or if you switch from an alternative device your first inhalation will be with Ventavis 10 microgram/ml (1 ml ampoule with white and yellow rings).
Estonian: Ventavis'e ravi alustamisel või üleminekul mõnelt muult seadmelt, kasutate esimesel inhalatsioonil Ventavis't tugevusega 10 mikrogrammi/ml (1 ml ampull, mis on märgistatud valge ja kollase rõngaga).
English: If this dose is well tolerated, dosing should be increased to 5 microgram iloprost and maintained at that dose.
Estonian: Kui selle annuse taluvus on hea, tuleb annust tõsta 5 mikrogrammi iloprostini ning jätkata ravi selle annusega.
English: At initiation of Ventavis treatment with Venta-Neb the first inhaled dose should be 2.5 microgram iloprost as delivered at the mouthpiece of the nebuliser using 2 ml ampoule of Ventavis 10 microgram/ml.
Estonian: Venta-Neb'iga Ventavis-ravi alustamisel on esimene inhaleeritav annus 2,5 mikrogrammi iloprosti, doseerituna huuliku juures, kasutades Ventavis 10 mikrogrammi/ml 2 ml-st ampulli.
English: • 3 ml ampoules, colourless, glass type I, containing 2 ml nebuliser solution, ring coded with two coloured rings (white - pink).
Estonian: • 3 ml ampullid, värvitust I tüüpi klaasist, sisaldavad 2 ml nebuliseeritavat lahust, märgistatud kahe värvilise rõngaga (valge-roosa).
English: 168 (4 x 42) AMPOULES WITH 1 ML CO-PACKED WITH BREELIB CONSUMABLES SET
Estonian: 168 (4 x 42) AMPULLI 1 ML LAHUSEGA, PAKENDATUD KOOS BREELIB'I TARVIKUTEGA
English: First dosing with 2.5 microgram should be done even if patients had already been stable on 5 microgram inhaled with an alternative device (see section 4.2).
Estonian: Isegi, kui patsiendid inhaleerisid muu seadmega stabiilselt 5 mikrogrammi, peab esimene annus Breelib'i puhul olema 2,5 mikrogrammi (vt lõik 4.2).
English: Ventavis 10 microgram/ml nebuliser solution (1 ml ampoule) delivers 2.5 microgram and Ventavis 20 microgram/ml nebuliser solution delivers 5 microgram at the mouthpiece of the Breelib nebuliser.
Estonian: Ventavis 10 mikrogrammi/ml nebuliseeritava lahuse (1 ml ampull) puhul doseeritakse Breelib nebulisaatori huuliku juures 2,5 mikrogrammi iloprosti, Ventavis 20 mikrogrammi/ml nebuliseeritava lahuse puhul aga 5 mikrogrammi iloprosti.
English: Frequently observed symptoms following overdose are dizziness, headache, flushing, nausea, jaw pain or back pain.
Estonian: Üleannustamise sümptomid on peamiselt seotud iloprosti veresooni laiendava toimega; sageli on täheldatud pearingluse, peavalu, punetuse, iivelduse, lõualuuvõi seljavalu esinemist.
English: The risk of bleeding may be increased in patients when potential inhibitors of platelet aggregation or anticoagulants are given concomitantly (see section 4.5).
Estonian: Trombotsüütide agregatsiooni võimalike inhibiitorite või antikoagulantide samaaegne manustamine võib suurendada patsientide veritsusriski (vt lõik 4.5).
English: Syncope is a common symptom of the disease itself and can also occur under therapy.
Estonian: Minestus on haiguse enda sage sümptom, mis võib esineda ka ravi ajal.
English: Ventavis 20 microgram/ml; 1 ml
Estonian: Ventavis 20 mikrogrammi/ml; 1 ml
English: Management
Estonian: Tegutsemine
English: At initiation of Ventavis treatment with I-Neb system the first inhaled dose should be 2.5 microgram iloprost as delivered at the mouthpiece of the nebuliser using 1 ml ampoule of Ventavis 10 microgram/ml.
Estonian: I-Neb süsteemiga Ventavis-ravi alustamisel on esimene inhaleeritav annus 2,5 mikrogrammi iloprosti, doseerituna huuliku juures, kasutades Ventavis 10 mikrogrammi/ml 1 ml-st ampulli.
English: 30 AMPOULES WITH 1 ML
Estonian: 30 ampulli x 1 ml
English: • For the 2.5 microgram dose the medication chamber with the red latch is used together with the red control disc.
Estonian: • 2,5 mikrogrammise annuse jaoks kasutatakse punase fiksaatoriga ravimikambrit koos punase kontrollkettaga.
English: To obtain the optimal droplet size for the administration of Ventavis the green baffle plate should be used.
Estonian: Optimaalse aerosooli tilga suuruse saamiseks kasutage Ventavis'e manustamisel rohelist deflektorplaati.
English: For the 5 microgram dose of Ventavis 20 microgram/ml the medication chamber with the gold coloured latch is used together with the gold control disc.
Estonian: 5 mikrogrammise annuse jaoks Ventavis 20 mikrogrammi/ml manustamisel kasutatakse kuldse fiksaatoriga ravimikambrit koos kuldse kontrollkettaga.
English: Ventavis 20 microgram/ml
Estonian: Ventavis 20 mikrogrammi/ml
English: 90 ampoules with 2 ml.
Estonian: 90 ampulli x 2 ml
English: • For the 2.5 microgram dose the medication chamber with the red coloured latch is used together with the red control disc.
Estonian: • 2,5 mikrogrammise annuse jaoks kasutatakse punase fiksaatoriga ravimikambrit koos punase kontrollkettaga;
English: 42 AMPOULES WITH 1 ML
Estonian: 42 AMPULLI 1 ML LAHUSEGA
English: • 168 (4x42) ampoules co-packed with Breelib consumables set (containing 1 mouthpiece and 1
Estonian: • 168 (4 x 42) ampulli, pakendatud koos Breelib'i tarvikutega (sisaldab 1 huulikut ja
English: Multipack: 168 (4 x 42) ampoules with 1 ml co-packed with Breelib consumables set (containing 1 mouthpiece and 1 medication chamber).
Estonian: Mitmikpakend: 168 (4 x 42) ampulli 1 ml lahusega, pakendatuna koos Breelib'i tarvikutega (sisaldab 1 huulikut ja 1 ravimikambrit).
English: Ventavis 10 microgram/ml
Estonian: Ventavis 10 mikrogrammi/ml
English: For patients being switched from an alternative device to the Breelib nebuliser the first inhalation should be made with Ventavis 10 microgram/ml (1ml ampoule) delivering 2.5 microgram iloprost at the mouthpiece and under close medical supervision to ensure that the faster inhalation provided by Breelib is well tolerated.
Estonian: Tagamaks, et kiiremat inhalatsiooni Breelib'i abil talutakse hästi, tuleb patsiendi üleminekul muult seadmelt Breelib nebulisaatorile teha esimene inhalatsioon arsti hoolika järelevalve all Ventavis'e tugevusega 10 mikrogrammi/ml (1 ml ampull), mis doseerib Breelib nebulisaatori huuliku juures 2,5 mikrogrammi iloprosti.
English: EU/1/03/255/014 [168 (4 x 42) x 1 ml] co-packed with Breelib consumables set (containing 1 mouthpiece and 1 medication chamber).
Estonian: EU/1/03/255/014 [168 (4 x 42) x 1 ml] pakendatuna koos Breelib'i tarvikutega (sisaldab 1 huulikut ja 1 ravimikambrit).
English: EU/1/03/255/013 [168 (4 x 42) x 1 ml] co-packed with Breelib consumables set (containing 1 mouthpiece and 1 medication chamber).
Estonian: EU/1/03/255/013 [168 (4 x 42) x 1 ml], pakendatuna koos Breelib'i tarvikutega (sisaldab 1 huulikut ja 1 ravimikambrit).
English: • P2 Programme 2: 2.5 microgram active substance on the mouth piece 10 inhalation cycles.
Estonian: • P2 Programm 2: 2,5 mikrogrammi toimeainet huulikul, 10 inhalatsioonitsüklit.
English: • 1 ml ampoules, colourless, glass type I, containing 1 ml nebuliser solution, ring coded with two coloured rings (white - yellow).
Estonian: • 1 ml ampullid, värvitust I tüüpi klaasist, sisaldavad 1 ml nebuliseeritavat lahust, märgistatud kahe värvilise rõngaga (valge-kollane).
English: 42 ampoules with 1 ml.
Estonian: 42 ampulli x 1 ml.
English: Ventavis 10 microgram/ml; 2 ml
Estonian: Ventavis 10 mikrogrammi/ml; 2 ml
English: Only patients who are maintained at the 5 microgram dose and who have repeatedly experienced extended inhalation times with Ventavis 10 microgram/ml, which could result in incomplete inhalation, may be considered suitable for switching to Ventavis 20 microgram/ml.
Estonian: Üleminekut Ventavis'e tugevusele 20 mikrogrammi/ml võib pidada sobivaks ainult patsientidele, kelle säilitusannus on 5 mikrogrammi ja kellel on inhalatsiooniaeg Ventavis 10 mikrogrammi/ml manustamisel korduvalt pikenenud (see võib põhjustada mittetäielikku inhalatsiooni).
English: Ventavis 10 microgram/ml nebuliser solution Ventavis 20 microgram/ml nebuliser solution
Estonian: Ventavis 10 mikrogrammi/ml nebuliseeritav lahus Ventavis 20 mikrogrammi/ml nebuliseeritav lahus
English: Dyspnoea Pharyngolaryngeal pain
Estonian: Ravimikambri fiksaator
English: • P1 Programme 1: 5 microgram active substance on the mouth piece 25 inhalation cycles.
Estonian: • P1 Programm 1: 5 mikrogrammi toimeainet huulikul, 25 inhalatsioonitsüklit.
English: P1 Programme 1: 5 microgram active substance on the mouth piece 25 inhalation cycles.
Estonian: P1 programm 1: 5 mikrogrammi toimeainet huulikul, 25 inhalatsioonitsüklit.
English: P2 Programme 2: 2.5 microgram active substance on the mouth piece 10 inhalation cycles.
Estonian: P2 programm 2: 2,5 mikrogrammi toimeainet huulikul, 10 inhalatsioonitsüklit.
English: Vascular disorders
Estonian: trombotsütopeenia
English: Ventavis 10 microgram/ml; 1 ml
Estonian: Ventavis 10 mikrogrammi/ml; 1 ml
English: Ventavis 10 mcg/ml (1 ml ampoule with white and yellow rings)
Estonian: 10 mikrogrammi/ml (1 ml ampull, mis on märgistatud valge ja kollase rõngaga)
English: Different nebuliser devices can be used to administer Ventavis 20µg/ml.
Estonian: Ventavis 20 mikrogrammi/ml manustamiseks saab kasutada erinevaid nebulisaatoreid.
English: Each ampoule with 1 ml contains 10 microgram iloprost.
Estonian: Üks ampull 1 ml lahusega sisaldab 10 mikrogrammi iloprosti.
English: Ventavis 10 microgram/ml nebuliser solution (1 ml ampoule)
Estonian: Ventavis 10 mikrogrammi/ml nebuliseeritav lahus (1 ml ampull)
English: • 1 ml ampoules, colourless, glass type I, containing 1 ml nebuliser solution, ring coded with two coloured rings (yellow - red).
Estonian: • 1 ml ampullid, värvitust I tüüpi klaasist, sisaldavad 1 ml nebuliseeritavat lahust, märgistatud kahe värvilise rõngaga (kollane-punane).
English: 300 ampoules with 2 ml.
Estonian: 300 ampulli x 2 ml
English: Ventavis should only be initiated and monitored by a physician experienced in the treatment of pulmonary hypertension.
Estonian: I-Neb AAD Ventavis'e ravi võib määrata ja seda jälgida ainult pulmonaalse hüpertensiooni ravi kogemustega arst.
English: 30 ampoules with 2 ml.
Estonian: 30 ampulli x 2 ml.
English: • Ventavis 20 microgram/ml:
Estonian: • Ventavis 20 mikrogrammi/ml
English: Ventavis 10 microgram/ml nebuliser solution 1 ml solution contains 10 microgram iloprost (as iloprost trometamol).
Estonian: Ventavis 10 mikrogrammi/ml nebuliseeritav lahus 1 ml lahust sisaldab 10 mikrogrammi iloprosti (iloprosttrometamoolina).
English: • Ventavis 10 microgram/ml:
Estonian: • Ventavis 10 mikrogrammi/ml
English: Ventavis 20 microgram/ml nebuliser solution 1 ml solution contains 20 microgram iloprost (as iloprost trometamol).
Estonian: Ventavis 20 mikrogrammi/ml nebuliseeritav lahus 1 ml lahust sisaldab 20 mikrogrammi iloprosti (iloprosttrometamoolina).
English: It imitates a natural substance in the body called prostacyclin.
Estonian: See toimib sarnaselt kehas toodetava aine prostatsükliiniga.
English: Each ampoule with 2 ml contains 20 microgram iloprost.
Estonian: Üks ampull 2 ml lahusega sisaldab 20 mikrogrammi iloprosti.
English: The ampoules containing 2 ml are marked with two coloured rings (white - pink).
Estonian: 2 ml ampullidel on kaks värvilist rõngast (valge-roosa).
English: Multipack: 90 (3 x 30) ampoules with 2 ml.
Estonian: Mitmikpakend: 90 (3 x 30) ampulli x 2 ml 100 ampulli x 2 ml
English: Comparable systemic exposures (AUC (0-tlast)) and approximately 30% higher maximum serum concentrations (Cmax) were found following inhalation of Ventavis 20 microgram/ml compared to Ventavis 10 microgram/ml which was in line with the observed shorter inhalation time using Ventavis 20 microgram/ml.
Estonian: Ventavis tugevuse 20 mikrogrammi/ml inhaleerimisel olid süsteemsed vereplasma tasemed (AUC (0-tviimane) võrreldavad ja maksimaalne plasmakontsentratsioon (Cmax) ligikaudu 30% suurem, kui Ventavis tugevuse 10 mikrogrammi/ml korral.
English: In general, when starting Ventavis treatment the first inhaled dose should be 2.5 microgram iloprost as delivered at the mouthpiece.
Estonian: Ventavis'e ravi alustamisel peab esimene inhaleeritav annus olema üldjuhul 2,5 mikrogrammi iloprosti, doseerituna huuliku juures.
English: 30 ampoules with 1 ml.
Estonian: 30 AMPULLI 1 ML LAHUSEGA
English: Each ampoule with 1 ml contains 20 microgram iloprost.
Estonian: Üks ampull 1 ml lahusega sisaldab 20 mikrogrammi iloprosti.
English: Ventavis 10 microgram/ml, Nebuliser solution Iloprost
Estonian: Ventavis 10 mikrogrammi/ml nebuliseeritav lahus Iloprostum
English: No study has been performed with Ventavis in children with pulmonary hypertension.
Estonian: Pulmonaalse hüpertensiooniga lastel ei ole uuringuid Ventavis'ega läbi viidud.